Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ocugen, Inc.OCGN · Entity 5550 | See Remarks | January 02, 2025 | January 06, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ocugen, Inc.
Report date January 02, 2025 · Filed January 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 306,197 |
Reported balance
After 2025-01-03 transaction · row 1
1 source rowRow 1 · 2025-01-03 · Tax withholding · Disposed 41,633 · Balance 306,197 |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.90 · Expires 2035-01-02 | Direct | 730,994 |
Reported balance
After 2025-01-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-01-02 · Grant · Acquired 730,994 · Balance 730,994 F1: The option vests annually in equal installments over three years commencing on January 2, 2026, subject to continued service with the Issuer on the applicable vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests annually in equal installments over three years commencing on January 2, 2026, subject to continued service with the Issuer on the applicable vesting dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2025 Filed Jan 6, 2025 22:02 UTC | Ocugen, Inc. OCGN · Entity 5550 | Tax withholdingCommon Stock | 41,633 | $0.89 | $37,240.72 |
DisclosureSEC source: 0001062993-25-000406 · form4.xml · nonDerivative · entry 1 Upadhyay Arun · CIK 0001960039 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 306,197 Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:02 UTC | Ocugen, Inc. OCGN · Entity 5550 | GrantOption (Right to Buy) · Derivative | 730,994 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001062993-25-000406 · form4.xml · derivative · entry 2 Upadhyay Arun · CIK 0001960039 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 730,994 Underlying: Common Stock · 730,994 shares Expires 2035-01-02 F1 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on January 2, 2026, subject to continued service with the Issuer on the applicable vesting dates. Read SEC document |
| September 16, 2024 Filed Sep 26, 2024 20:27 UTC | Ocugen, Inc. OCGN · Entity 5550 | Tax withholdingCommon Stock | 842 | $1.17 | $985.14 |
DisclosureSEC source: 0001062993-24-017006 · form4.xml · nonDerivative · entry 1 Upadhyay Arun · CIK 0001960039 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 347,830 Read SEC document |
| June 17, 2024 Filed Jul 2, 2024 20:09 UTC | Ocugen, Inc. OCGN · Entity 5550 | Tax withholdingCommon Stock | 917 | $1.42 | $1,302.14 |
DisclosureSEC source: 0001062993-24-013292 · form4.xml · nonDerivative · entry 1 Upadhyay Arun · CIK 0001960039 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 348,672 Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:47 UTC | Ocugen, Inc. OCGN · Entity 5550 | Tax withholdingCommon Stock | 41,633 | $0.65 | $27,186.35 |
DisclosureSEC source: 0001062993-24-000558 · form4.xml · nonDerivative · entry 1 Upadhyay Arun · CIK 0001960039 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,589 Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:04 UTC | Ocugen, Inc. OCGN · Entity 5550 | GrantOption (Right to Buy) · Derivative | 137,795 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001062993-24-000473 · form4.xml · derivative · entry 1 Upadhyay Arun · CIK 0001960039 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,795 Underlying: Common Stock · 137,795 shares Expires 2034-01-02 F1 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on January 2, 2025, subject to continued service with the Issuer on the applicable vesting dates. Read SEC document |
| September 16, 2023 Filed Sep 19, 2023 20:01 UTC | Ocugen, Inc. OCGN · Entity 5550 | Tax withholdingCommon Stock | 842 | $0.41 | $345.22 |
DisclosureSEC source: 0001062993-23-018252 · form4.xml · nonDerivative · entry 1 Upadhyay Arun · CIK 0001960039 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 391,222 Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 20:24 UTC | Ocugen, Inc. OCGN · Entity 5550 | Tax withholdingCommon Stock | 917 | $0.51 | $467.67 |
DisclosureSEC source: 0001062993-23-013810 · form4.xml · nonDerivative · entry 1 Upadhyay Arun · CIK 0001960039 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,064 Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:12 UTC | Ocugen, Inc. OCGN · Entity 5550 | GrantOption (Right to Buy) · Derivative | 379,357 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001062993-23-000490 · form4.xml · derivative · entry 2 Upadhyay Arun · CIK 0001960039 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,357 Underlying: Common Stock · 379,357 shares Expires 2033-01-03 F2 · derivative.exercise_date: The option vests annually in equal installments over three years commencing on January 3, 2024, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:12 UTC | Ocugen, Inc. OCGN · Entity 5550 | GrantCommon Stock | 315,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000490 · form4.xml · nonDerivative · entry 1 Upadhyay Arun · CIK 0001960039 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,083 F1 · security: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Ocugen Inc.'s (the "Company's") common stock. The RSUs vest annually in three equal installments commencing on January 3, 2024, subject to continued service with the Company on the applicable vesting dates. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock. Read SEC document |
| January 03, 2023 Filed Feb 17, 2023 22:12 UTC | Ocugen, Inc. OCGN · Entity 5550 | Tax withholdingCommon Stock | 7,102 | $1.25 | $8,877.50 |
DisclosureSEC source: 0001062993-23-004084 · form4.xml · nonDerivative · entry 1 Upadhyay Arun · CIK 0001960039 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 392,981 F1 · date: This Form 4 is being filed late due to an administrative error. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.